Wright Medical Group NV operates as a global medical device company, which engages in the design, manufacture, and distribution of biologic products. It provides surgical solutions for the foot and ankle market and its products include large joint implants for the hip and knee, extremity implants for the shoulder, elbow, hand, wrist and foot and biologic products, including bone graft substitutes. The company was founded by Frank O. Wright in 1950 and is headquartered in Arlington, TN.
Industry, Sector and Symbol
Industry Surgical appliances & supplies
Sub-IndustryHealth Care Equipment
SectorMedical
Phone31-20-521-4777
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$836.19 million
Profitability
Miscellaneous
Employees2,894
Next Earnings Date5/8/2019 (Estimated)
OptionableOptionable
Wright Medical Group (NASDAQ:WMGI) Frequently Asked Questions
What is Wright Medical Group's stock symbol?
Wright Medical Group trades on the NASDAQ under the ticker symbol "WMGI."
How often does Wright Medical Group pay dividends? What is the dividend yield for Wright Medical Group?
Wright Medical Group announced a dividend on Tuesday, December 11th. Shareholders of record on Wednesday, December 5th will be given a dividend of $1.50 per share on Monday, December 10th. The ex-dividend date of this dividend is Wednesday, December 12th. View Wright Medical Group's Dividend History.
How were Wright Medical Group's earnings last quarter?
Wright Medical Group NV (NASDAQ:WMGI) posted its earnings results on Tuesday, February, 26th. The medical device company reported $0.11 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $0.06 by $0.05. The medical device company earned $238.15 million during the quarter, compared to analysts' expectations of $237.86 million. Wright Medical Group had a negative net margin of 20.27% and a positive return on equity of 0.02%. The company's revenue was up 9.4% compared to the same quarter last year. During the same period last year, the firm posted $0.10 earnings per share. View Wright Medical Group's Earnings History.
When is Wright Medical Group's next earnings date?
How can I listen to Wright Medical Group's earnings call?
Wright Medical Group will be holding an earnings conference call on Wednesday, May 8th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link.
What guidance has Wright Medical Group issued on next quarter's earnings?
Wright Medical Group updated its FY19 earnings guidance on Tuesday, February, 26th. The company provided EPS guidance of $0.17-0.25 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.24. The company issued revenue guidance of $954-966 million, compared to the consensus revenue estimate of $960.65 million.Wright Medical Group also updated its FY 2019 guidance to $0.17-0.25 EPS.
What price target have analysts set for WMGI?
14 analysts have issued 12-month price targets for Wright Medical Group's stock. Their predictions range from $30.00 to $40.00. On average, they anticipate Wright Medical Group's stock price to reach $34.6154 in the next twelve months. This suggests a possible upside of 9.5% from the stock's current price. View Analyst Price Targets for Wright Medical Group.
What is the consensus analysts' recommendation for Wright Medical Group?
14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Wright Medical Group in the last year. There are currently 2 hold ratings and 12 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Wright Medical Group.
What are Wall Street analysts saying about Wright Medical Group stock?
Here are some recent quotes from research analysts about Wright Medical Group stock:
- 1. Needham & Company LLC analysts commented, "WMGI’s 4Q18 revenue was consistent with its preannouncement while EBITDA and EPS beat consensus. For 2019, management provided revenue, EBITDA, and EPS guidance that all bracketed consensus. Organic revenue growth slowed to 10.1% (adjusted for selling days) from 14.4% in 3Q18 as strong US Lower Extremities growth was offset by slower US Upper Extremities growth (faced its toughest comp of the year). Given the improving Lower Extremities growth, Augment Injectable launch, and Cartiva acquisition, we have increased confidence that WMGI can exceed consensus in 2019 despite some likely moderation in its US Upper Extremities growth and we reiterate our Buy rating." (2/27/2019)
- 2. Cantor Fitzgerald analysts commented, "We reiterate our Overweight rating and a 12-month price target of $35 on shares of WMGI. We think WMGI is positioned to outperform expectations in 2018 with multiple drivers across each of its three primary segments (lower extremities, upper extremities, and biologics) to accelerate growth. We see WMGI’s valuation as attractive, as we expect innovative products to help WMGI to capitalize on the evolving market trends. Valuation Summary We base our $35 price target on a ~5.5x EV/Sales multiple on our 2019 sales estimate." (12/10/2018)
Has Wright Medical Group been receiving favorable news coverage?
Media stories about WMGI stock have been trending neutral on Monday, InfoTrie Sentiment Analysis reports. InfoTrie identifies negative and positive news coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Wright Medical Group earned a coverage optimism score of 0.2 on InfoTrie's scale. They also gave news stories about the medical device company a news buzz of 3.0 out of 10, indicating that recent news coverage is unlikely to have an impact on the company's share price in the immediate future.
Who are some of Wright Medical Group's key competitors?
Some companies that are related to Wright Medical Group include Steris (STE), WILLIAM DEMANT/ADR (WILYY), MSA Safety (MSA), Inogen (INGN), Avanos Medical (AVNS), Establishment Labs (ESTA), RTI Surgical (RTIX), Sientra (SIEN), Invacare (IVC), ConforMIS (CFMS), Lakeland Industries (LAKE), COLLPLANT HOLDI/S (CLGN), Rewalk Robotics (RWLK), NanoVibronix (NAOV) and Wound Management Technologies (WNDM).
What other stocks do shareholders of Wright Medical Group own?
Who are Wright Medical Group's key executives?
Wright Medical Group's management team includes the folowing people:
- Robert J. Palmisano, President, CEO & Executive Director
- Lance A. Berry, Executive VP, Chief Financial & Operations Officer
- Jonathan Wesley Porter, Chief Compliance Officer & Senior Vice President
- Kevin D. Cordell, Executive VP & Chief Global Commercial Officer
- James Andrew Lightman, Secretary, Senior Vice President & General Counsel
Who are Wright Medical Group's major shareholders?
Wright Medical Group's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include FMR LLC (15.00%), BlackRock Inc. (7.28%), Orbimed Advisors LLC (3.92%), Fisher Asset Management LLC (2.38%), Macquarie Group Ltd. (2.03%) and Northern Trust Corp (1.48%). Company insiders that own Wright Medical Group stock include David D Stevens, Elizabeth H Weatherman, Gregory Morrison, James Lightman, Jennifer S Walker, John L Miclot, Jonathan Wesley Porter, Julie Andrews, Kevin C Oboyle, Kevin D Cordell, Lance A Berry, Patrick Fisher, Peter Cooke, Richard F Wallman and Robert P Burrows III. View Institutional Ownership Trends for Wright Medical Group.
Which major investors are selling Wright Medical Group stock?
WMGI stock was sold by a variety of institutional investors in the last quarter, including Macquarie Group Ltd., Barclays PLC, Orbimed Advisors LLC, Westfield Capital Management Co. LP, Tekla Capital Management LLC, Keeley Teton Advisors LLC, GSA Capital Partners LLP and GW&K Investment Management LLC. Company insiders that have sold Wright Medical Group company stock in the last year include David D Stevens, Elizabeth H Weatherman, James Lightman, Jennifer S Walker, John L Miclot, Julie Andrews, Kevin C Oboyle, Kevin D Cordell, Lance A Berry, Patrick Fisher, Peter Cooke and Robert P Burrows III. View Insider Buying and Selling for Wright Medical Group.
Which major investors are buying Wright Medical Group stock?
WMGI stock was purchased by a variety of institutional investors in the last quarter, including Fiera Capital Corp, Norges Bank, Partner Fund Management L.P., Columbus Circle Investors, Castleark Management LLC, Dimensional Fund Advisors LP, Dimensional Fund Advisors LP and Impax Asset Management Group plc. View Insider Buying and Selling for Wright Medical Group.
How do I buy shares of Wright Medical Group?
Shares of WMGI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Wright Medical Group's stock price today?
One share of WMGI stock can currently be purchased for approximately $31.62.
How big of a company is Wright Medical Group?
Wright Medical Group has a market capitalization of $3.98 billion and generates $836.19 million in revenue each year. Wright Medical Group employs 2,894 workers across the globe.
What is Wright Medical Group's official website?
How can I contact Wright Medical Group?
Wright Medical Group's mailing address is PRINS BERNHARDPLEIN 200, AMSTERDAM P7, 1097 JB. The medical device company can be reached via phone at 31-20-521-4777 or via email at [email protected]
MarketBeat Community Rating for Wright Medical Group (NASDAQ WMGI)
MarketBeat's community ratings are surveys of what our community members think about Wright Medical Group and other stocks. Vote "Outperform" if you believe WMGI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe WMGI will underperform the S&P 500 over the long term. You may vote once every thirty days.
